| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65162-339-91 | 65162-339 | HUMAN PRESCRIPTION DRUG | Dapsone | Dapsone | GEL | TOPICAL | 20231024 | N/A | ANDA | ANDA209890 | Amneal Pharmaceuticals LLC | DAPSONE | 50 mg/g | 1 TUBE in 1 CARTON (65162-339-91) / 90 g in 1 TUBE |
| 65162-339-85 | 65162-339 | HUMAN PRESCRIPTION DRUG | Dapsone | Dapsone | GEL | TOPICAL | 20231024 | N/A | ANDA | ANDA209890 | Amneal Pharmaceuticals LLC | DAPSONE | 50 mg/g | 1 TUBE in 1 CARTON (65162-339-85) / 60 g in 1 TUBE |
| 65162-339-63 | 65162-339 | HUMAN PRESCRIPTION DRUG | Dapsone | Dapsone | GEL | TOPICAL | 20231024 | N/A | ANDA | ANDA209890 | Amneal Pharmaceuticals LLC | DAPSONE | 50 mg/g | 1 TUBE in 1 CARTON (65162-339-63) / 30 g in 1 TUBE |